Skip to main content

Mass Spectrometric DNA Adduct Quantification by Multiple Reaction Monitoring and Its Future Use for the Molecular Epidemiology of Cancer

  • Chapter
  • First Online:
Advancements of Mass Spectrometry in Biomedical Research

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 806))

Abstract

The formation of DNA adducts is considered essential for tumor initiation. Quantification of DNA adducts may be achieved by various techniques of which LC-MS/MS-based multiple reaction monitoring has become the most prominent in the past decade. Adducts of single nucleosides are analyzed following enzymatic break-down of a DNA sample following adduct enrichment usually by solid-phase extraction. LC-MS/MS quantification is carried out using stable isotope-labeled internal reference substances. An upcoming challenge is the use of DNA adducts as biomarkers either for internal exposure to electrophilic genotoxins or for the approximation of cancer risk. Here we review recent studies in which DNA adducts were quantified by LC-MS/MS in DNA samples from human matrices. We outline a possible way for future research to aim at the development of an “adductome” approach for the characterization of DNA adduct spectra in human tissues. The DNA adduct spectrum reflects the inner exposure of an individual’s tissue to electrophilic metabolites and, therefore, should replace the conventional and inaccurate external exposure in epidemiological studies in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

2-AAF:

2-Acetylaminofluorene

4-ABP:

4-Aminobiphenyl

BaP:

Benzo[a]pyrene

CYP:

Cytochrome P450 monooxygenase

dA:

2′-Deoxyadenosine

dC:

2′-Deoxycytidine

dG:

2′-Deoxyguanosine

HAA:

Heterocyclic aromatic amine

LC-MS/MS:

Liquid chromatography—tandem mass spectrometry

MP:

1-Methylpyrene

MRM:

Multiple reaction monitoring

PAH:

Polycyclic aromatic hydrocarbon

PhIP:

2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine

TLC:

Thin-layer chromatography

References

  1. Angerer J, Ewers U, Wilhelm M (2007) Human biomonitoring: state of the art. Int J Hyg Environ Health 210:201–228

    Article  CAS  Google Scholar 

  2. Baasanjav-Gerber C, Monien BH, Mewis I, Schreiner M, Barillari J, Iori R et al (2011) Identification of glucosinolate congeners able to form DNA adducts and to induce mutations upon activation by myrosinase. Mol Nutr Food Res 55:783–792

    Article  CAS  Google Scholar 

  3. Bartsch H, Arab K, Nair J (2011) Biomarkers for hazard identification in humans. Environ Health 10 suppl 1:S11

    Article  Google Scholar 

  4. Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B, Marques MM (1999) Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem Res Toxicol 12:68–77

    Article  CAS  Google Scholar 

  5. Benford D, Bolger PM, Carthew P, Coulet M, DiNovi M, Leblanc JC et al (2010) Application of the margin of exposure (MOE) approach to substances in food that are genotoxic and carcinogenic. Food Chem Toxicol 48(suppl 1):S2–S24

    Article  CAS  Google Scholar 

  6. Bessette EE, Spivack SD, Goodenough AK, Wang T, Pinto S, Kadlubar FF et al (2010) Identification of carcinogen DNA adducts in human saliva by linear quadrupole ion trap/multistage tandem mass spectrometry. Chem Res Toxicol 23:1234–1244

    Article  CAS  Google Scholar 

  7. Brown K, Tompkins EM, Boocock DJ, Martin EA, Farmer PB, Turteltaub KW et al (2007) Tamoxifen forms DNA adducts in human colon after administration of a single [14C]-labeled therapeutic dose. Cancer Res 67:6995–7002

    Article  CAS  Google Scholar 

  8. Chen L, Wang M, Villalta PW, Luo X, Feuer R, Jensen J et al (2007) Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. Chem Res Toxicol 20:108–113

    Article  CAS  Google Scholar 

  9. Chou PH, Kageyama S, Matsuda S, Kanemoto K, Sasada Y, Oka M et al (2010) Detection of lipid peroxidation-induced DNA adducts caused by 4-oxo-2(E)-nonenal and 4-oxo-2(E)-hexenal in human autopsy tissues. Chem Res Toxicol 23:1442–1448

    Article  CAS  Google Scholar 

  10. Embrechts J, Lemiere F, Van Dongen W, Esmans EL, Buytaert P, Van Marck E et al (2003) Detection of estrogen DNA-adducts in human breast tumor tissue and healthy tissue by combined nano LC-nano ES tandem mass spectrometry. J Am Soc Mass Spectrom 14:482–491

    Article  CAS  Google Scholar 

  11. Farmer PB, Brown K, Tompkins E, Emms VL, Jones DJ, Singh R et al (2005) DNA adducts: mass spectrometry methods and future prospects. Toxicol Appl Pharmacol 207:293–301

    Article  CAS  Google Scholar 

  12. Farmer PB, Singh R (2008) Use of DNA adducts to identify human health risk from exposure to hazardous environmental pollutants: the increasing role of mass spectrometry in assessing biologically effective doses of genotoxic carcinogens. Mutat Res 659:68–76

    Article  CAS  Google Scholar 

  13. Felton JS, Knize MG, Shen NH, Lewis PR, Andresen BD, Happe J et al (1986) The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 7:1081–1086

    Article  CAS  Google Scholar 

  14. Glatt HR (2006) Metabolic factors affecting the mutagenicity of heterocyclic amines. In: Skog K, Alexander J (eds) Acrylamide and Other Health Hazardous Compounds in Heat-treated Foods. Woodhead Publishing, Cambridge, pp 358–404

    Chapter  Google Scholar 

  15. Godschalk RW, Van Schooten FJ, Bartsch H (2003) A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J Biochem Mol Biol 36:1–11

    Article  CAS  Google Scholar 

  16. Goodenough AK, Schut HA, Turesky RJ (2007) Novel LC-ESI/MS/MS(n) method for the characterization and quantification of 2′-deoxyguanosine adducts of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by 2-D linear quadrupole ion trap mass spectrometry. Chem Res Toxicol 20:263–276

    Article  CAS  Google Scholar 

  17. Gorlewska-Roberts K, Green B, Fares M, Ambrosone CB, Kadlubar FF (2002) Carcinogen-DNA adducts in human breast epithelial cells. Environ Mol Mutagen 39:184–192

    Article  CAS  Google Scholar 

  18. Gu D, Turesky RJ, Tao Y, Langouet SA, Nauwelaers GC, Yuan JM et al (2012) DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 4-aminobiphenyl are infrequently detected in human mammary tissue by liquid chromatography/tandem mass spectrometry. Carcinogenesis 33:124–130

    Article  CAS  Google Scholar 

  19. Guengerich FP (2003) Activation of dihaloalkanes by thiol-dependent mechanisms. J Biochem Mol Biol 36:20–27

    Article  CAS  Google Scholar 

  20. Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, Langouet S (1998) Activation and detoxification of aflatoxin B1. Mutat Res 402:121–128

    Article  CAS  Google Scholar 

  21. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    Article  CAS  Google Scholar 

  22. International Agency for Research on Cancer (2008) 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide), vol 97. International Agency for Research on Cancer, Lyon

    Google Scholar 

  23. International Agency for Research on Cancer (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines, vol 89. International Agency for Research on Cancer, Lyon

    Google Scholar 

  24. International Agency for Research on Cancer (2010) Some aromatic amines, organic dyes, and related exposures, vol 99. International Agency for Research on Cancer, Lyon

    Google Scholar 

  25. International Agency for Research on Cancer (2010) Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures, vol 92. International Agency for Research on Cancer, Lyon

    Google Scholar 

  26. Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19:1847–1853

    Article  CAS  Google Scholar 

  27. Klaene JJ, Sharma VK, Glick J, Vouros P (2012) The analysis of DNA adducts: the transition from 32P-postlabeling to mass spectrometry. Cancer Lett 334:10–19

    Article  Google Scholar 

  28. Ma L, Kuhlow A, Glatt HR (2002) Ethanol enhances the activation of 1-hydroxymethylpyrene to DNA adduct-forming species in the rat. Polycycl Aromat Comp 22:933–946

    Article  CAS  Google Scholar 

  29. Matsuda T, Tao H, Goto M, Yamada H, Suzuki M, Wu Y et al (2013) Lipid peroxidation-induced DNA adducts in human gastric mucosa. Carcinogenesis 34:121–127

    Article  CAS  Google Scholar 

  30. Monien BH, Engst W, Barknowitz G, Seidel A, Glatt HR (2012) Mutagenicity of 5-hydroxymethylfurfural in V79 cells expressing human SULT1A1: identification and mass spectrometric quantification of DNA adducts formed. Chem Res Toxicol 25:1484–1492

    Article  CAS  Google Scholar 

  31. Monien BH, Herrmann K, Florian S, Glatt HR (2011) Metabolic activation of furfuryl alcohol: formation of 2-methylfuranyl DNA adducts in Salmonella typhimurium strains expressing human sulfotransferase 1A1 and in FVB/N mice. Carcinogenesis 32:1533–1539

    Article  CAS  Google Scholar 

  32. Monien BH, Müller C, Bakhiya N, Donath C, Frank H, Seidel A et al (2009) Probenecid, an inhibitor of transmembrane organic anion transporters, alters tissue distribution of DNA adducts in 1-hydroxymethylpyrene-treated rats. Toxicology 262:80–85

    Article  CAS  Google Scholar 

  33. Monien BH, Müller C, Engst W, Frank H, Seidel A, Glatt HR (2008) Time course of hepatic 1-methylpyrene DNA adducts in rats determined by isotope dilution LC-MS/MS and 32P-postlabeling. Chem Res Toxicol 21:2017–2025

    Article  CAS  Google Scholar 

  34. Nair J, Carmichael PL, Fernando RC, Phillips DH, Strain AJ, Bartsch H (1998) Lipid peroxidation-induced etheno-DNA adducts in the liver of patients with the genetic metal storage disorders Wilson’s disease and primary hemochromatosis. Cancer Epidemiol Biomarkers Prev 7:435–440

    CAS  Google Scholar 

  35. Newcomb PA, Solomon C, White E (1999) Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat 53:271–277

    Article  CAS  Google Scholar 

  36. Otteneder M, Lutz WK (1999) Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat Res 424:237–247

    Article  CAS  Google Scholar 

  37. Paini A, Scholz G, Marin-Kuan M, Schilter B, O’Brien J, van Bladeren PJ et al (2011) Quantitative comparison between in vivo DNA adduct formation from exposure to selected DNA-reactive carcinogens, natural background levels of DNA adduct formation and tumour incidence in rodent bioassays. Mutagenesis 26:605–618

    Article  CAS  Google Scholar 

  38. Perera F, Mayer J, Jaretzki A, Hearne S, Brenner D, Young TL et al (1989) Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls. Cancer Res 49:4446–4451

    CAS  Google Scholar 

  39. Phillips DH (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23:1979–2004

    Article  CAS  Google Scholar 

  40. Phillips DH, Castegnaro M (1999) Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 14:301–315

    Article  CAS  Google Scholar 

  41. Poirier MC (2004) Chemical-induced DNA damage and human cancer risk. Nat Rev Cancer 4:630–637

    Article  CAS  Google Scholar 

  42. Poirier MC, Beland FA (1992) DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: implications for DNA adduct-based human cancer risk assessment. Chem Res Toxicol 5:749–755

    Article  CAS  Google Scholar 

  43. Poirier MC, Stanley JR, Beckwith JB, Weinstein IB, Yuspa SH (1982) Indirect immunofluorescent localization of benzo[a]pyrene adducted to nucleic acids in cultured mouse keratinocyte nuclei. Carcinogenesis 3:345–348

    Article  CAS  Google Scholar 

  44. Punt A, Delatour T, Scholz G, Schilter B, van Bladeren PJ, Rietjens IM (2007) Tandem mass spectrometry analysis of N 2-(trans-isoestragol-3′-yl)-2′-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1′-hydroxyestragole. Chem Res Toxicol 20:991–998

    Article  CAS  Google Scholar 

  45. Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE et al (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People’s Republic of China. Cancer Epidemiol Biomarkers Prev 3:3–10

    CAS  Google Scholar 

  46. Randerath K, Reddy MV, Gupta RC (1981) 32P-labeling test for DNA damage. Proc Natl Acad Sci U S A 78:6126–6129

    Article  CAS  Google Scholar 

  47. Reddy MV (2000) Methods for testing compounds for DNA adduct formation. Regul Toxicol Pharmacol 32:256–263

    Article  CAS  Google Scholar 

  48. Rendic S, Guengerich FP (2012) Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316–1383

    Article  CAS  Google Scholar 

  49. Ricicki EM, Soglia JR, Teitel C, Kane R, Kadlubar F, Vouros P (2005) Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue using capillary liquid chromatography-microelectrospray mass spectrometry. Chem Res Toxicol 18:692–699

    Article  CAS  Google Scholar 

  50. Shou M, Korzekwa KR, Crespi CL, Gonzalez FJ, Gelboin HV (1994) The role of 12 cDNA-expressed human, rodent, and rabbit cytochromes P450 in the metabolism of benzo[a]pyrene and benzo[a]pyrene trans-7,8-dihydrodiol. Mol Carcinog 10:159–168

    Article  CAS  Google Scholar 

  51. Singh R, Gaskell M, Le Pla RC, Kaur B, Azim-Araghi A, Roach J et al (2006) Detection and quantitation of benzo[a]pyrene-derived DNA adducts in mouse liver by liquid chromatography-tandem mass spectrometry: comparison with 32P-postlabeling. Chem Res Toxicol 19:868–878

    Article  CAS  Google Scholar 

  52. Singh R, Teichert F, Seidel A, Roach J, Cordell R, Cheng MK et al (2010) Development of a targeted adductomic method for the determination of polycyclic aromatic hydrocarbon DNA adducts using online column-switching liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 24:2329–2340

    Article  CAS  Google Scholar 

  53. Smith B, Cadby P, Leblanc JC, Setzer RW (2010) Application of the margin of exposure (MoE) approach to substances in food that are genotoxic and carcinogenic: example: methyleugenol, CASRN: 93-15-2. Food Chem Toxicol 48(suppl 1):S89–S97

    Article  CAS  Google Scholar 

  54. Spodheim-Maurizot M, Saint-Ruf G, Leng M (1980) Antibodies to N-hydroxy-2-aminofluorene modified DNA as probes in the study of DNA reacted with derivatives of 2-acetylaminofluorene. Carcinogenesis 1:807–812

    Article  CAS  Google Scholar 

  55. Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S et al (2001) Association between carcinogen-DNA adducts in white blood cells and lung cancer risk in the physicians health study. Cancer Res 61:6708–6712

    CAS  Google Scholar 

  56. Vineis P, Husgafvel-Pursiainen K (2005) Air pollution and cancer: biomarker studies in human populations. Carcinogenesis 26:1846–1855

    Article  CAS  Google Scholar 

  57. Zhang S, Balbo S, Wang M, Hecht SS (2010) Analysis of acrolein-derived 1, N2-propanodeoxyguanosine adducts in human leukocyte DNA from smokers and nonsmokers. Chem Res Toxicol 24:119–124

    Article  Google Scholar 

  58. Zhu J, Chang P, Bondy ML, Sahin AA, Singletary SE, Takahashi S et al (2003) Detection of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine-DNA adducts in normal breast tissues and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12:830–837

    CAS  Google Scholar 

Download references

Acknowledgments

The author gratefully acknowledges financial support from the German Research Foundation (MO 2520/1-1) and the German Institute of Human Nutrition (DIfE).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bernhard H. Monien .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Monien, B.H. (2014). Mass Spectrometric DNA Adduct Quantification by Multiple Reaction Monitoring and Its Future Use for the Molecular Epidemiology of Cancer. In: Woods, A., Darie, C. (eds) Advancements of Mass Spectrometry in Biomedical Research. Advances in Experimental Medicine and Biology, vol 806. Springer, Cham. https://doi.org/10.1007/978-3-319-06068-2_18

Download citation

Publish with us

Policies and ethics